CORRESP

September 23, 2024

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

 

Attention:

Jimmy McNamara

 

Re:

BioAge Labs, Inc. (the “Registrant”)

Registration Statement on Form S-1 (File No. 333-281901)

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between September 18, 2024 and the date hereof, approximately 1,808 copies of the Preliminary Prospectus, dated September 18, 2024, were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement, as amended.

We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

We hereby join in the request of the Registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Wednesday, September 25, 2024 or as soon thereafter as practicable.

[signature page follows]


  Very truly yours,
 
 

GOLDMAN SACHS & CO. LLC

MORGAN STANLEY & CO. LLC

JEFFERIES LLC

CITIGROUP GLOBAL MARKETS INC.

As representatives of the Underwriters

 
  GOLDMAN SACHS & CO. LLC
  By: /s/ Lyla Bibi Maduri
  Name: Lyla Bibi Maduri
  Title: Managing Director
 
  MORGAN STANLEY & CO. LLC
  By: /s/ Kalli Dirks
  Name: Kalli Dirks
  Title: Managing Director
 
  JEFFERIES LLC
  By: /s/ Ashley Delp Walker
  Name: Ashley Delp Walker
  Title: Managing Director
 
  CITIGROUP GLOBAL MARKETS INC.
  By: /s/ Jason Jun
  Name: Jason Jun
  Title: Managing Director

 

 

[Signature Page to Acceleration Request Letter]